Chronic Periodontitis Clinical Trial
Official title:
Randomized Clinical Trial Assessing the Clinical Outcomes and Recolonization Patterns Following Scaling and Root Planing With and Without Using Er.YAG Laser in Chronic Periodontitis Patients
Dental bacterial plaque is the most frequent modifiable finding in patients with periodontal
(gum) diseases. Many studies have provided evidence that mechanical removal of dental plaque
is critical for improving the periodontal health. The standard initial treatment of
periodontitis (gum disease) is to remove plaque and calculus form the teeth and root
structures using sclaing and root planing (SRP). Typically hand instruments and an ultrasonic
scaler are used for SRP
While this method removes some of the bacteria that leads to periodontitis, microorganisms
are not completely eliminated through SRP. Studies have shown that after 3 months, the
bacteria initially present prior to scaling and root planing had recolonized. In order to
prevent recurrence of periodontitis, it is recommended that oral bacteria be kept at low
levels.
When used at the proper wave length, dental lasers have been shown to effectively removes
calculus, without damaging surrounding tissue. The Er:YAG laser has been FDA-approved for the
use of scaling and root planing in Dentistry. While studies on the Er:YAG laser have shown
that it is effective in removing calculus and preserving the tooth root structure, there is
no consensus of the level of calculus removal. The Er:YAG laser may also be more effective in
removing microbial bacteria than SRP with hand instruments and ultrasonic scaler.
The purpose of this study is to evaluate the effectiveness of the Er:YAG laser, as an adjunct
to scaling and root planing, in removing microbial bacteria. Participants with chronic
periodontitis will be randomized to have one quadrant undergo scaling and root planing using
hand instruments and ultrasonic scaler alone, while a second quadrant will receive the same
treatment, with the addition of the Er:YAG laser. Outcomes studies will be traditional
periodontal clinical parameters at 6 weeks and 3 months after treatment. Microbial cultures
will be performed at baseline and 3 months to compare survival and re-population by
periodontal microorganisms.
Status | Recruiting |
Enrollment | 56 |
Est. completion date | March 2018 |
Est. primary completion date | March 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients enrolled in the Post-Graduate Periodontology Clinic at Tufts University School of Dental Medicine (TUSDM) - Recent (within the past 30 days) diagnosis of moderate to severe chronic periodontitis in at least two quadrants according to the Armitage Classification - Have had full mouth and vertical bite-wing series of diagnostic radiographs exposed at TUSDM within 6 months preceding entry of the study as a standard of care - Have a treatment plan made by the original provider and certified by the PI based on the working diagnosis, presenting etiology, and the predicted therapeutic outcomes of the case (prognosis). - Each of the two selected quadrants should have at least 5 teeth including the canine, first premolar and second premolar in contact with at least one tooth that has = 5 mms and = 9 mms probing depths with bleeding on probing. Exclusion Criteria: - Participants must not have had mechanical debridement or any other professional periodontal therapy within 6 months preceding entering the study - Participants with significant chronic oral soft tissue pathology (lichen planus, Benign Mucous Membrane Pemphigoid, Steven Johnson's Syndrome, Sjogren's Syndrome, etc.) which might affect host response to the presence of bacteria. - Participants with fixed appliances or partial dentures, to standardize the effect of the treatment since they are plaque retentive. - Participants who smoke tobacco - Participants who require prophylactic antibiotics prior to dental treatment - Participants who have taken systemic antibiotic medications within the previous 6 months - Participants with uncontrolled systemic conditions or disease such as diabetes and immunological disorders - Participants with known drug allergies or known adverse effects following the use of oral hygiene products. - Participants who are pregnant or lactating - Teeth with grade III mobility or teeth with hopeless prognosis indicated for extraction |
Country | Name | City | State |
---|---|---|---|
United States | Tufts University School of Dental Medicine | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Tufts University School of Dental Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Probing Depth | Differences in pocket depth reduction between laser treatment and control groups will be analyzed with a linear mixed effects model. Four sites (mesiolingual, mesiobuccal, distolingual, and distobuccal) per tooth will be averaged and used in the linear mixed effects model. Normality of the data will be assessed graphically and with the Shapiro-Wilk test. | Up to 3 months | |
Primary | Change in Clinical Attachment Levels | Differences in attachment gain between laser treatment and control groups will be analyzed with a linear mixed effects model. Four sites (mesiolingual, mesiobuccal, distolingual, and distobuccal) per tooth will be averaged and used in the linear mixed effects model. Normality of the data will be assessed graphically and with the Shapiro-Wilk test. | Up to 3 months | |
Secondary | Change in Gingival Bleeding Index | The gingival bleeding index (the number of bleeding sites divided by the total number of sites) will be calculated. Statistical significance between the two groups' gingival bleeding index will be determined with generalized estimating equations. | Up to 3 months | |
Secondary | Change in Plaque Index | The plaque index (the number of surfaces with plaque divided by the total number of surfaces) will be calculated. Statistical significance between the two groups' plaque index will be determined with generalized estimating equations. | Up to 3 months | |
Secondary | Change in microbial load, measured in Colony Forming Units (CFUs) | Microbial load will be measured by the total number of cultivable bacteria measured by total viable colony forming units (CFUs) on non-selective and selective media. Percent cultivability of periodontal pathogens will be measured by number of pathogen specific CFUs in proportion to total cultivability. Differences in microbial load will be investigated with the paired t-test. If the assumption of normality is unmet, the Wilcoxon rank-sum test will be used instead. |
baseline, 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06400069 -
Role of NLRP6 in Chronic Periodontitis
|
||
Completed |
NCT05231096 -
Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis
|
N/A | |
Completed |
NCT03203746 -
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03354338 -
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
|
Phase 2 | |
Completed |
NCT02516111 -
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
|
Phase 2/Phase 3 | |
Terminated |
NCT02568163 -
Influence of Stress on Non Surgical Periodontal Treatment
|
N/A | |
Completed |
NCT02174146 -
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
|
N/A | |
Completed |
NCT02430519 -
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
|
N/A | |
Completed |
NCT01233765 -
Analysis of Neutrophil Response in Chronic Periodontitis
|
N/A | |
Completed |
NCT01438333 -
Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection
|
N/A | |
Completed |
NCT02218515 -
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
|
Phase 4 | |
Completed |
NCT02197260 -
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
|
Phase 4 | |
Not yet recruiting |
NCT03270280 -
Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis
|
Phase 2 | |
Not yet recruiting |
NCT04026828 -
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
|
||
Completed |
NCT04643288 -
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
|
N/A | |
Completed |
NCT04697199 -
The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis
|
Phase 1 | |
Completed |
NCT03039244 -
Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers
|
N/A | |
Completed |
NCT02898675 -
Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing
|
N/A | |
Completed |
NCT03874390 -
Effects of Ozone Therapy on Clinical Parameters and Inflammatory Cytokines in Chronic Periodontitis Patients
|
N/A | |
Completed |
NCT02518152 -
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
|
Phase 2/Phase 3 |